An analysis of flexibility and quality improvement in a quality-adjusted EOQ model with finite-range stochastic lead-time

被引:7
|
作者
Nasri, Farrokh [1 ]
Paknejad, Javad [1 ]
Affisco, John F. [1 ]
机构
[1] 134 Hofstra Univ, Frank G Zarb Sch Business, Dept IT QM, Hempstead, NY 11549 USA
关键词
Inventory; Flexibility improvement; Quality improvement; Stochastic inventory; INVENTORY MODEL; COST; REDUCTION;
D O I
10.1016/j.cie.2012.03.019
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
Traditional Economic Order Quantity (EOQ) model operates under a series of highly restrictive assumptions, including, but not limited to, the assumptions of deterministic lead-time, perfect quality, and constant setup cost. Many variants of the traditional EOQ model have been developed as a result of relaxing one or more of these assumptions. These variants include a quality-adjusted EOQ model with finite-range stochastic lead-time which relaxed the deterministic lead-time and perfect quality assumptions. Utilizing the basic framework of the quality-adjusted model, the authors also considered the option of investment to improve the quality and obtained closed form relationships for the quality-adjusted and quality improvement models. This paper extends the previous work by investigating two additional models: one aimed at improving flexibility, through setup reduction, and the second considering the strategy of simultaneous investment in flexibility and quality improvement. Analytical and numerical results are presented for both models. These results indicate that significant savings over the quality-adjusted EOQ model with finite-range stochastic lead-time are realized for both the flexibility improvement and simultaneous models. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:418 / 427
页数:10
相关论文
共 50 条
  • [1] Treatment options for localized prostate cancer: Quality-adjusted life years and the effects of lead-time
    Bhatnagar, V
    Stewart, ST
    Bonney, WW
    Kaplan, RM
    UROLOGY, 2004, 63 (01) : 103 - 109
  • [2] AN INVENTORY MODEL WITH FINITE-RANGE STOCHASTIC LEAD TIMES
    SPHICAS, GP
    NASRI, F
    NAVAL RESEARCH LOGISTICS, 1984, 31 (04) : 609 - 616
  • [3] SETUP COST REDUCTION IN AN INVENTORY MODEL WITH FINITE-RANGE STOCHASTIC LEAD TIMES
    NASRI, F
    AFFISCO, JF
    PAKNEJAD, MJ
    INTERNATIONAL JOURNAL OF PRODUCTION RESEARCH, 1990, 28 (01) : 199 - 212
  • [4] On an EOQ model with service level constraint under fuzzy-stochastic demand and variable lead-time
    Rong, M.
    Maiti, M.
    APPLIED MATHEMATICAL MODELLING, 2015, 39 (17) : 5230 - 5240
  • [5] Estimation of loss of quality-adjusted life expectancy (QALE) for patients with operable versus inoperable lung cancer: Adjusting quality-of-life and lead-time bias for utility of surgery
    Yang, Szu-Chun
    Lai, Wu-Wei
    Chang, Han-Yu
    Su, Wu-Chou
    Chen, Helen H. W.
    Wang, Jung-Der
    LUNG CANCER, 2014, 86 (01) : 96 - 101
  • [6] Inter-dependent lead-time and ordering cost reduction strategy: a supply chain model with quality control, lead-time dependent backorder and price-sensitive stochastic demand
    Monami Das Roy
    Shib Sankar Sana
    OPSEARCH, 2021, 58 : 690 - 710
  • [7] Inter-dependent lead-time and ordering cost reduction strategy: a supply chain model with quality control, lead-time dependent backorder and price-sensitive stochastic demand
    Das Roy, Monami
    Sana, Shib Sankar
    OPSEARCH, 2021, 58 (03) : 690 - 710
  • [8] Quality-adjusted time without symptoms or toxicity analysis of interferon maintenance in multiple myeloma
    Zee, B
    Cole, B
    Li, T
    Browman, G
    James, K
    Johnston, D
    Sugano, D
    Pater, J
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2834 - 2839
  • [9] Regression analysis of mean quality-adjusted survival time based on pseudo-observations
    Tunes-da-Silva, G.
    Klein, J. P.
    STATISTICS IN MEDICINE, 2009, 28 (07) : 1054 - 1066
  • [10] Estimating quality-adjusted time without symptoms or toxicity using a multivariate failure time regression model
    Wang, J
    Sherrill, B
    Irish, WD
    VALUE IN HEALTH, 2005, 8 (06) : A8 - A9